NRX Pharmaceuticals
NRXP
NRXP
25 hedge funds and large institutions have $9.76M invested in NRX Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 22 → 25 (+3)
1.99% more ownership
Funds ownership: 13.36% → 15.35% (+2%)
Holders
25
Holding in Top 10
–
Calls
$145K
Puts
$18K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$305K | |
| 3 | +$232K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$159K |
| 5 |
Squarepoint
New York
|
+$106K |
Top Sellers
| 1 | -$140K | |
| 2 | -$57.6K | |
| 3 | -$30.8K | |
| 4 |
Morgan Stanley
New York
|
-$18.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$401 |